NCT06463054

Brief Summary

The investigators are interested in learning more about how the role of mothers' emotions has on the transmission of suicide risk to children. Eligible participants will be invited to participate in a baseline assessment, and 4 follow-up assessments in the next year. This research study is a randomized control trial. Participants that choose to enroll are randomly assigned, that is by chance (like by flipping a coin) to receive DBT Skills Training or treatment as usual (TAU). Participants may also be selected for DBT skills training, it which would occur once a week for 6 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
23mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Apr 2024Mar 2028

Study Start

First participant enrolled

April 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 17, 2024

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

4 years

First QC Date

May 23, 2024

Last Update Submit

May 14, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Child Suicidal Thoughts and Behaviors

    Suicidal thoughts and behaviors will be assessed by the Columbia Suicide Severity Rating Scale (C-SSRS). C-SSRS will be scored with these domains, higher scores indicate worse outcomes Suicidal Ideation (Highest Level Endorsed 1-5) Intensity of Ideation (2-25) Suicidal Behavior (present during time period) Y/N Medical Damage for Attempt (0-5) Potential Lethality (if medical damage = 0) (0-2)

    Baseline, All Follow-up time points (3, 6, 12, and 24 months

  • Child Suicidal Thoughts and Behaviors

    Suicidal thoughts and behaviors will be assessed the Intensity of Suicide Ideation Scale (SIS; PhenX Toolkit). Intensity of Ideation Subscale The sum ranges from 2 to 25, with the higher number indicating more intense ideation.

    Baseline, All Follow-up time points (3, 6, 12, and 24 months

Secondary Outcomes (2)

  • Child Mental Health Outcomes

    Baseline, All Follow-up time points (3, 6, 12, and 24 months)

  • Child Mental Health Outcomes

    Baseline, All Follow-up time points (3, 6, 12, and 24 months)

Study Arms (2)

Dialectical Behavior Therapy Skills Group Training

EXPERIMENTAL

The investigators will employ Dialectical Behavior Therapy Skills Training in order to experimentally manipulate maternal emotion dysregulation, our targeted mechanism.

Behavioral: Dialectical Behavior Therapy Skills Group Training

Safety Planning Intervention

EXPERIMENTAL

Safety Planning Intervention (SPI) or SPI only for 6 months, such that all mothers with history of suicidal behavior + ER difficulties will receive SPI.

Behavioral: Safety Planning Intervention

Interventions

The investigators will employ Dialectical Behavior Therapy Skills Training in order to experimentally manipulate maternal emotion dysregulation, the targeted mechanism.

Dialectical Behavior Therapy Skills Group Training

Safety Planning Intervention (SPI) or SPI only for 6 months, such that all mothers with history of suicidal behavior + ER difficulties will receive SPI.

Safety Planning Intervention

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsFemale mothers
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Biological mothers with legal custody of target child between 9-11
  • Confirmed lifetime Biological mothers with legal custody of target child between 9-11
  • Confirmed lifetime history of suicidal behavior for mothers of suicidal behavior for mothers

You may not qualify if:

  • Any mothers and children with major medical illnesses that might be associated with organic personality changes or ER difficulties (e.g. Parkinson's Disease, seizure disorders)
  • Cardiac nervous system abnormalities that would influence physiological readings
  • Previous DBT (Dialectical Behavior Therapy) in the last six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

RECRUITING

MeSH Terms

Conditions

Emotional Regulation

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Officials

  • Stephanie D Step, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer Wilson

CONTACT

Jennifer Stahler

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 23, 2024

First Posted

June 17, 2024

Study Start

April 1, 2024

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

March 31, 2028

Last Updated

May 15, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The investigators will archive data with the NIMH Data Archive (NDA) in two locations: (1) National Database for Clinical Trials Related to Mental Illness (NDCT), and (2) the Research Domain Criteria Database (RDoC db). Dr. Stepp will set up an NDA Account with access to NUID tool, and complete and submit an NDA Data Sharing Agreement for the project. The final dataset will cover clinical course and outcome data collected during the proposed project period. All data will be de-identified prior to submission to the NDCT and RDoCdb, and the team will obtain informed consent from participants to share their de-identified data. The investigators will fully comply with all NIH and IRB guidelines for data transfer, as well as federal regulations, including HIPAA.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
12 months after accomplishment of each primary aim or objective, or upon publication of the project's primary results.

Locations